Use of oral contraceptives in BRCA mutation carriers and risk for ovarian and breast cancer: a systematic review

PURPOSE: BRCA mutation carriers have an increased risk of developing breast or ovarian cancer. Oral contraception (OC) is known to increase breast cancer and reduce ovarian cancer risk in the general population. This review analyses the published data on OC and risk of cancer in BRCA mutation carrie...

Descripción completa

Detalles Bibliográficos
Autores principales: Huber, D., Seitz, S., Kast, K., Emons, G., Ortmann, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494665/
https://www.ncbi.nlm.nih.gov/pubmed/32140806
http://dx.doi.org/10.1007/s00404-020-05458-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494665/
https://www.ncbi.nlm.nih.gov/pubmed/32140806
http://dx.doi.org/10.1007/s00404-020-05458-w

Ejemplares similares